EUCI — Eurocine Vaccines AB Income Statement
0.000.00%
Last trade - 00:00
- SEK22.39m
- SEK21.08m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.9 | 8.91 | 18.2 | 20.1 | 18.4 |
Operating Profit | -20.9 | -8.91 | -18.2 | -20.1 | -18.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -21.1 | -9.22 | -18.3 | -20.2 | -18.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.1 | -9.22 | -18.3 | -20.2 | -18.4 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.1 | -9.22 | -18.3 | -20.2 | -18.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.1 | -9.22 | -18.3 | -20.2 | -18.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.53 | -0.662 | -0.594 | -0.359 | -0.221 |
Dividends per Share |